Skip to main content
Indian stocks: Visit www.stage2stocks.com →

Zhongchao Inc. Class A

Stage 4 · Declining · week 21

As of Oct 22, 2026, Zhongchao is in Stage 4, the downtrend phase, now in week 21 (since May 28, 2026). It closed at $1.29, 99.9% below its 52-week high and below its 200-day average, which is falling.

Zhongchao Inc. provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People's Republic of China. More about the company

$1.29
-33.85% today
$5.7M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is ZCMD early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 47w
S4 23w
S4 30w
S4 21w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 4w → S3 2w → S4 47w → S1 7w → S2 12w → S3 1w → S2 6w → S3 9w → S4 23w → S1 1w → S4 30w → S1 2w → S4 21w current
Total tracked: 166 weeks across 13 stage runs.

ZCMD among Health Information Services41st of 41 by relative strength

All 41 →
Stocks in Health Information Services ranked by relative strength, with stage and one-month change
#StockStageRS1M
1AMWLStage 2 · wk 2597+7.4%
2HNGEStage 2 · wk 2096+19.1%
3BTSGStage 3 · wk 894+9.1%
4NRCStage 3 · wk 493−0.1%
5SOPHStage 2 · wk 2491−12.7%
6HTFLStage 2 · wk 1087+17.0%
7HSTMStage 2 · wk 1777+20.3%
8OMCLStage 4 · wk 1070+12.5%
…41ZCMDStage 4 · wk 211−34.7%
vs 52W High
-99.9%
$1.29 lo$2,279.62 hi
99.9% below 52W high, deep Stage 4 damage
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 21
1w13w26w
Week 21, extended decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-99.7%
200 DMA: $406.72 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
0.06x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-34.7%
3M
-53.9%
6M
-99.8%
YTD
-99.9%
1Y
-99.9%
Scan Membership
Breakout Watch
Latest: 2025-01-14
6 appearances in last 60 days. First seen: 2021-03-24.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 21 · Vol 0.06x
2026-10-21S4
Wk 21 · Vol 0.04x
2026-10-20S4
Wk 21 · Vol 0.07x
2026-10-19S4
Wk 20 · Vol 0.10x
2026-10-16S4
Wk 20 · Vol 0.10x
2026-10-15S4
Wk 20 · Vol 0.05x
2026-10-14S4
Wk 20 · Vol 0.22x
2026-10-13S4
Wk 20 · Vol 0.08x
2026-10-12S4
Wk 19 · Vol 0.10x
2026-10-09S4
Wk 19 · Vol 0.11x
2026-10-08S4
Wk 19 · Vol 0.09x
2026-10-07S4
Wk 19 · Vol 0.09x
Moving averages & range
50 DMA
$1.71
200 DMA
$406.72
52W High
$2,279.62
52W Low
$1.29
5D Low
$1.29
Resistance levels (recent highs)
20d High
$1.95
60d High
$2.56
120d High
$825.84
250d High
$2,181.41
Next resistance
+51.2%
to 20d High
ROE
-24.9%
Profit margin -55.5%
Dividend Yield
0.00%
P/B 0.0

Zhongchao: quick answers

What stage is Zhongchao in?

As of Oct 22, 2026, Zhongchao (ZCMD) is in Stage 4, the downtrend phase. It entered Stage 4 on May 28, 2026 and is in week 21. What the four stages mean

Is Zhongchao in an uptrend?

No. Zhongchao is in a Stage 4 downtrend. It trades 99.7% below its 200-day average, which is falling.

How far is Zhongchao from its 52-week high?

Zhongchao closed at $1.29 on Oct 22, 2026, 99.9% below its 52-week high of $2,279.62. Its 52-week low is $1.29.

How has Zhongchao performed over the past year?

As of Oct 22, 2026, Zhongchao is down 99.9% over the past year and down 99.9% so far in 2026.

Which sector and industry is Zhongchao in?

Zhongchao is in the Health Information Services industry, part of the Health Care sector.

About this companyHealth Care· Health Information Services

Zhongchao Inc. provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People's Republic of China. It operates through two segments, MDMOOC services, and Sales of Patented Drugs. The company offers patient management services in the tumor and rare diseases field, internet healthcare services, and pharmaceutical services, and operates an online information platform. It also provides online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes on popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content. The company offers its services through its MDMOOC online platform, such as the MDMOOC mobile app, MOOC Medical WeChat subscription account, and MDMOOC website, and patient management services through an IT system under the Zhongxun brand, WeChat mini program, and Zhongxin Health WeChat mini program. It serves pharmaceutical enterprises and non-profit organizations, including medical associations, medical institutions, medical journals, medical foundations, and hospitals, as well as healthcare professionals, nurses, and doctors. Zhongchao Inc. was founded in 2012 and is headquartered in Shanghai, China.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.